世界のダサチニブAPI市場インサイト・予測(~2027)

QYResearchが発行した調査報告書(QY21AUG0812)
◆英語タイトル:Global Dasatinib API Market Insights and Forecast to 2027
◆商品コード:QY21AUG0812
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年8月(※2024年版があります。お問い合わせください。)
◆ページ数:96
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:化学&材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはダサチニブAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。ダサチニブAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(純度≥98%、純度<98%)、用途別市場規模(ダサチニブ錠、その他)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・ダサチニブAPIの世界市場概要
・メーカー別の競争状況、市場シェア
・ダサチニブAPIの種類別市場規模:純度≥98%、純度<98%
・ダサチニブAPIの用途別市場規模:ダサチニブ錠、その他
・北米のダサチニブAPI市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパのダサチニブAPI市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアのダサチニブAPI市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米のダサチニブAPI市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカのダサチニブAPI市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:Dr. Reddy's Laboratories、ChemWerth Inc、Teva API、Sun Pharmaceutical、Hubei Haosun Pharmaceutical、ALP Pharm、Sichuan Xieli Pharmaceutical、Boryung Pharmaceutical Co., Ltd
・ダサチニブAPIのバリューチェーン・販売チャネル分析
・ダサチニブAPIの世界市場動向
【レポートの概要】

Dasatinib is a selective tyrosine kinase receptor inhibitor that is used in the therapy of chronic myelogenous leukemia (CML) positive for the Philadelphia chromosome. Dasatinib is commonly associated with transient elevations in serum aminotransferase levels during treatment, but with only rare instances of clinically apparent acute liver injury.

Market Analysis and Insights: Global Dasatinib API Market
The global Dasatinib API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Dasatinib API Scope and Segment
Dasatinib API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dasatinib API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity<98% Segment by Application Dasatinib Tablets Others By Company Dr. Reddy's Laboratories ChemWerth Inc Teva API Sun Pharmaceutical Hubei Haosun Pharmaceutical ALP Pharm Sichuan Xieli Pharmaceutical Boryung Pharmaceutical Co., Ltd Production by Region North America India China South Korea Consumption by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

【レポートの目次】

1 Study Coverage
1.1 Dasatinib API Product Introduction
1.2 Market by Type
1.2.1 Global Dasatinib API Market Size Growth Rate by Type
1.2.2 Purity≥98%
1.2.3 Purity<98% 1.3 Market by Application 1.3.1 Global Dasatinib API Market Size Growth Rate by Application 1.3.2 Dasatinib Tablets 1.3.3 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Dasatinib API Production 2.1 Global Dasatinib API Production Capacity (2016-2027) 2.2 Global Dasatinib API Production by Region: 2016 VS 2021 VS 2027 2.3 Global Dasatinib API Production by Region 2.3.1 Global Dasatinib API Historic Production by Region (2016-2021) 2.3.2 Global Dasatinib API Forecasted Production by Region (2022-2027) 2.4 North America 2.5 India 2.6 China 2.7 South Korea 3 Global Dasatinib API Sales in Volume & Value Estimates and Forecasts 3.1 Global Dasatinib API Sales Estimates and Forecasts 2016-2027 3.2 Global Dasatinib API Revenue Estimates and Forecasts 2016-2027 3.3 Global Dasatinib API Revenue by Region: 2016 VS 2021 VS 2027 3.4 Global Top Dasatinib API Regions by Sales 3.4.1 Global Top Dasatinib API Regions by Sales (2016-2021) 3.4.2 Global Top Dasatinib API Regions by Sales (2022-2027) 3.5 Global Top Dasatinib API Regions by Revenue 3.5.1 Global Top Dasatinib API Regions by Revenue (2016-2021) 3.5.2 Global Top Dasatinib API Regions by Revenue (2022-2027) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Dasatinib API Production Capacity by Manufacturers 4.2 Global Dasatinib API Sales by Manufacturers 4.2.1 Global Top Dasatinib API Manufacturers by Sales (2016-2021) 4.2.2 Global Top Dasatinib API Manufacturers Market Share by Sales (2016-2021) 4.2.3 Global Top 10 and Top 5 Companies by Dasatinib API Sales in 2020 4.3 Global Dasatinib API Revenue by Manufacturers 4.3.1 Global Top Dasatinib API Manufacturers by Revenue (2016-2021) 4.3.2 Global Top Dasatinib API Manufacturers Market Share by Revenue (2016-2021) 4.3.3 Global Top 10 and Top 5 Companies by Dasatinib API Revenue in 2020 4.4 Global Dasatinib API Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Dasatinib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Dasatinib API Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Dasatinib API Sales by Type 5.1.1 Global Dasatinib API Historical Sales by Type (2016-2021) 5.1.2 Global Dasatinib API Forecasted Sales by Type (2022-2027) 5.1.3 Global Dasatinib API Sales Market Share by Type (2016-2027) 5.2 Global Dasatinib API Revenue by Type 5.2.1 Global Dasatinib API Historical Revenue by Type (2016-2021) 5.2.2 Global Dasatinib API Forecasted Revenue by Type (2022-2027) 5.2.3 Global Dasatinib API Revenue Market Share by Type (2016-2027) 5.3 Global Dasatinib API Price by Type 5.3.1 Global Dasatinib API Price by Type (2016-2021) 5.3.2 Global Dasatinib API Price Forecast by Type (2022-2027) 6 Market Size by Application 6.1 Global Dasatinib API Sales by Application 6.1.1 Global Dasatinib API Historical Sales by Application (2016-2021) 6.1.2 Global Dasatinib API Forecasted Sales by Application (2022-2027) 6.1.3 Global Dasatinib API Sales Market Share by Application (2016-2027) 6.2 Global Dasatinib API Revenue by Application 6.2.1 Global Dasatinib API Historical Revenue by Application (2016-2021) 6.2.2 Global Dasatinib API Forecasted Revenue by Application (2022-2027) 6.2.3 Global Dasatinib API Revenue Market Share by Application (2016-2027) 6.3 Global Dasatinib API Price by Application 6.3.1 Global Dasatinib API Price by Application (2016-2021) 6.3.2 Global Dasatinib API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Dasatinib API Market Size by Type 7.1.1 North America Dasatinib API Sales by Type (2016-2027) 7.1.2 North America Dasatinib API Revenue by Type (2016-2027) 7.2 North America Dasatinib API Market Size by Application 7.2.1 North America Dasatinib API Sales by Application (2016-2027) 7.2.2 North America Dasatinib API Revenue by Application (2016-2027) 7.3 North America Dasatinib API Sales by Country 7.3.1 North America Dasatinib API Sales by Country (2016-2027) 7.3.2 North America Dasatinib API Revenue by Country (2016-2027) 7.3.3 United States 7.3.4 Canada 8 Europe 8.1 Europe Dasatinib API Market Size by Type 8.1.1 Europe Dasatinib API Sales by Type (2016-2027) 8.1.2 Europe Dasatinib API Revenue by Type (2016-2027) 8.2 Europe Dasatinib API Market Size by Application 8.2.1 Europe Dasatinib API Sales by Application (2016-2027) 8.2.2 Europe Dasatinib API Revenue by Application (2016-2027) 8.3 Europe Dasatinib API Sales by Country 8.3.1 Europe Dasatinib API Sales by Country (2016-2027) 8.3.2 Europe Dasatinib API Revenue by Country (2016-2027) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Dasatinib API Market Size by Type 9.1.1 Asia Pacific Dasatinib API Sales by Type (2016-2027) 9.1.2 Asia Pacific Dasatinib API Revenue by Type (2016-2027) 9.2 Asia Pacific Dasatinib API Market Size by Application 9.2.1 Asia Pacific Dasatinib API Sales by Application (2016-2027) 9.2.2 Asia Pacific Dasatinib API Revenue by Application (2016-2027) 9.3 Asia Pacific Dasatinib API Sales by Region 9.3.1 Asia Pacific Dasatinib API Sales by Region (2016-2027) 9.3.2 Asia Pacific Dasatinib API Revenue by Region (2016-2027) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 China Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 10 Latin America 10.1 Latin America Dasatinib API Market Size by Type 10.1.1 Latin America Dasatinib API Sales by Type (2016-2027) 10.1.2 Latin America Dasatinib API Revenue by Type (2016-2027) 10.2 Latin America Dasatinib API Market Size by Application 10.2.1 Latin America Dasatinib API Sales by Application (2016-2027) 10.2.2 Latin America Dasatinib API Revenue by Application (2016-2027) 10.3 Latin America Dasatinib API Sales by Country 10.3.1 Latin America Dasatinib API Sales by Country (2016-2027) 10.3.2 Latin America Dasatinib API Revenue by Country (2016-2027) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Dasatinib API Market Size by Type 11.1.1 Middle East and Africa Dasatinib API Sales by Type (2016-2027) 11.1.2 Middle East and Africa Dasatinib API Revenue by Type (2016-2027) 11.2 Middle East and Africa Dasatinib API Market Size by Application 11.2.1 Middle East and Africa Dasatinib API Sales by Application (2016-2027) 11.2.2 Middle East and Africa Dasatinib API Revenue by Application (2016-2027) 11.3 Middle East and Africa Dasatinib API Sales by Country 11.3.1 Middle East and Africa Dasatinib API Sales by Country (2016-2027) 11.3.2 Middle East and Africa Dasatinib API Revenue by Country (2016-2027) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Dr. Reddy's Laboratories 12.1.1 Dr. Reddy's Laboratories Corporation Information 12.1.2 Dr. Reddy's Laboratories Overview 12.1.3 Dr. Reddy's Laboratories Dasatinib API Sales, Price, Revenue and Gross Margin (2016-2021) 12.1.4 Dr. Reddy's Laboratories Dasatinib API Product Description 12.1.5 Dr. Reddy's Laboratories Recent Developments 12.2 ChemWerth Inc 12.2.1 ChemWerth Inc Corporation Information 12.2.2 ChemWerth Inc Overview 12.2.3 ChemWerth Inc Dasatinib API Sales, Price, Revenue and Gross Margin (2016-2021) 12.2.4 ChemWerth Inc Dasatinib API Product Description 12.2.5 ChemWerth Inc Recent Developments 12.3 Teva API 12.3.1 Teva API Corporation Information 12.3.2 Teva API Overview 12.3.3 Teva API Dasatinib API Sales, Price, Revenue and Gross Margin (2016-2021) 12.3.4 Teva API Dasatinib API Product Description 12.3.5 Teva API Recent Developments 12.4 Sun Pharmaceutical 12.4.1 Sun Pharmaceutical Corporation Information 12.4.2 Sun Pharmaceutical Overview 12.4.3 Sun Pharmaceutical Dasatinib API Sales, Price, Revenue and Gross Margin (2016-2021) 12.4.4 Sun Pharmaceutical Dasatinib API Product Description 12.4.5 Sun Pharmaceutical Recent Developments 12.5 Hubei Haosun Pharmaceutical 12.5.1 Hubei Haosun Pharmaceutical Corporation Information 12.5.2 Hubei Haosun Pharmaceutical Overview 12.5.3 Hubei Haosun Pharmaceutical Dasatinib API Sales, Price, Revenue and Gross Margin (2016-2021) 12.5.4 Hubei Haosun Pharmaceutical Dasatinib API Product Description 12.5.5 Hubei Haosun Pharmaceutical Recent Developments 12.6 ALP Pharm 12.6.1 ALP Pharm Corporation Information 12.6.2 ALP Pharm Overview 12.6.3 ALP Pharm Dasatinib API Sales, Price, Revenue and Gross Margin (2016-2021) 12.6.4 ALP Pharm Dasatinib API Product Description 12.6.5 ALP Pharm Recent Developments 12.7 Sichuan Xieli Pharmaceutical 12.7.1 Sichuan Xieli Pharmaceutical Corporation Information 12.7.2 Sichuan Xieli Pharmaceutical Overview 12.7.3 Sichuan Xieli Pharmaceutical Dasatinib API Sales, Price, Revenue and Gross Margin (2016-2021) 12.7.4 Sichuan Xieli Pharmaceutical Dasatinib API Product Description 12.7.5 Sichuan Xieli Pharmaceutical Recent Developments 12.8 Boryung Pharmaceutical Co., Ltd 12.8.1 Boryung Pharmaceutical Co., Ltd Corporation Information 12.8.2 Boryung Pharmaceutical Co., Ltd Overview 12.8.3 Boryung Pharmaceutical Co., Ltd Dasatinib API Sales, Price, Revenue and Gross Margin (2016-2021) 12.8.4 Boryung Pharmaceutical Co., Ltd Dasatinib API Product Description 12.8.5 Boryung Pharmaceutical Co., Ltd Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Dasatinib API Industry Chain Analysis 13.2 Dasatinib API Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Dasatinib API Production Mode & Process 13.4 Dasatinib API Sales and Marketing 13.4.1 Dasatinib API Sales Channels 13.4.2 Dasatinib API Distributors 13.5 Dasatinib API Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Dasatinib API Industry Trends 14.2 Dasatinib API Market Drivers 14.3 Dasatinib API Market Challenges 14.4 Dasatinib API Market Restraints 15 Key Finding in The Global Dasatinib API Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

...

【掲載企業】

Dr. Reddy's Laboratories、ChemWerth Inc、Teva API、Sun Pharmaceutical、Hubei Haosun Pharmaceutical、ALP Pharm、Sichuan Xieli Pharmaceutical、Boryung Pharmaceutical Co., Ltd

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のダサチニブAPI市場インサイト・予測(~2027)(Global Dasatinib API Market Insights and Forecast to 2027)]についてメールでお問い合わせはこちらでお願いします。